T. Rowe Price Associates’s Aerie Pharmaceuticals, Inc. AERI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q4
Sell
-28,234
Closed -$428K 3039
2022
Q3
$428K Buy
28,234
+12,519
+80% +$190K ﹤0.01% 2201
2022
Q2
$118K Buy
15,715
+4,203
+37% +$31.6K ﹤0.01% 2717
2022
Q1
$105K Sell
11,512
-1,892
-14% -$17.3K ﹤0.01% 2830
2021
Q4
$94K Sell
13,404
-15,700
-54% -$110K ﹤0.01% 2883
2021
Q3
$332K Sell
29,104
-201
-0.7% -$2.29K ﹤0.01% 2538
2021
Q2
$469K Buy
29,305
+1,252
+4% +$20K ﹤0.01% 2409
2021
Q1
$501K Buy
28,053
+52
+0.2% +$929 ﹤0.01% 2360
2020
Q4
$378K Buy
28,001
+4,190
+18% +$56.6K ﹤0.01% 2351
2020
Q3
$280K Sell
23,811
-6,041
-20% -$71K ﹤0.01% 2313
2020
Q2
$441K Buy
29,852
+2,988
+11% +$44.1K ﹤0.01% 2096
2020
Q1
$363K Sell
26,864
-324,489
-92% -$4.38M ﹤0.01% 2124
2019
Q4
$8.49M Sell
351,353
-9,814
-3% -$237K ﹤0.01% 1339
2019
Q3
$6.94M Sell
361,167
-3,876
-1% -$74.5K ﹤0.01% 1339
2019
Q2
$10.8M Buy
365,043
+25
+0% +$739 ﹤0.01% 1300
2019
Q1
$17.3M Sell
365,018
-2,122
-0.6% -$101K ﹤0.01% 1217
2018
Q4
$13.3M Buy
367,140
+820
+0.2% +$29.6K ﹤0.01% 1258
2018
Q3
$22.5M Buy
366,320
+5,974
+2% +$368K ﹤0.01% 1183
2018
Q2
$24.3M Buy
360,346
+18,727
+5% +$1.26M ﹤0.01% 1142
2018
Q1
$18.5M Buy
341,619
+13,948
+4% +$757K ﹤0.01% 1206
2017
Q4
$19.6M Buy
327,671
+54,298
+20% +$3.24M ﹤0.01% 1188
2017
Q3
$13.3M Buy
273,373
+41,971
+18% +$2.04M ﹤0.01% 1273
2017
Q2
$12.2M Sell
231,402
-207,577
-47% -$10.9M ﹤0.01% 1283
2017
Q1
$19.9M Buy
438,979
+412,309
+1,546% +$18.7M ﹤0.01% 1166
2016
Q4
$1.01M Buy
26,670
+10
+0% +$378 ﹤0.01% 1777
2016
Q3
$1.01M Buy
+26,660
New +$1.01M ﹤0.01% 1744
2014
Q4
Sell
-502,224
Closed -$10.4M 2570
2014
Q3
$10.4M Buy
+502,224
New +$10.4M ﹤0.01% 1298